XCL1 and acute lymphoblastic leukemia: In a cohort of 33 patients with ALL, researchers evaluated the levels of X-C motif chemokine ligand 1 (XCL1) in the serum of peripheral blood at diagnosis, at the end of remission induction, and at the end of consolidation.